Hosted on MSN

Prehospital ECG linked to lower cardiac mortality

Studies show that performing 12-lead ECGs before hospital arrival improves acute coronary syndrome care, reducing mortality and enabling faster interventions. Detecting ischemia early can identify ...
STAT

AliveCor gets FDA nod for portable 12-lead, AI-powered ECG device

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...
MarketWatch

Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI(TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
MarketWatch

HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market

The MarketWatch News Department was not involved in the creation of this content. -- Marks HeartBeam's transition to commercial company -- Rapidly growing practice and highly engaged member population ...
Nasdaq

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...

Alivecor Launches AI-Powered Kardia 12L In Europe: The World's First Handheld 12-Lead ECG With A Unique Single-Cable Design

The World's First Handheld 12-Lead ECG With A Unique Single-Cable Design. Now CE Marked, the Kardia 12L ECG System leverages AI to detect 35 cardiac determinations, simplifying the ECG process and ...
Nasdaq

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...